Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

9.15
Delayed Data
As of 3:59pm ET
 -0.10 / -1.08%
Today’s Change
6.10
Today|||52-Week Range
13.80
+8.67%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Szela Mary J
Chief Executive Officer
Sale5/09/20172,248$9.42$21.2K-2.87%
Perry Gregory D
Corporate Officer
Sale5/09/2017710$9.42$6.7K-2.87%
Aryeh Jason M
Director
Buy5/15/2017361$8.95$3.2K+2.01%
Harshbarger Benjamin J
General Counsel
Sale5/15/2017232$8.97$2.1K+2.01%
Louis Roger W
Corporate Officer
Sale5/09/2017162$9.42$1.5K-2.87%
Harshbarger Benjamin J
General Counsel
Sale5/09/2017121$9.42$1.1K-2.87%
Harshbarger Benjamin J
General Counsel
Sale5/09/2017113$9.42$1.1K-2.87%
Buono Linda
Senior Vice President-Human Resources
Sale5/09/201793$9.42$876.06-2.87%
Harshbarger Benjamin J
General Counsel
Sale4/01/201757$10.74$612.18-15.43%
Smith Sandford D
Director
Buy1/27/2017456$0.00$0.00-2.45%
Page of 2